JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

36.83 -1.84

Buy Sell

Overview

Share price change

24h

Current

Min

36.62

Max

37.57

Key metrics
By Trading Economics
Income	11M 51M
Sales	39M 239M
P/E Sector Avg	11.786 90.422
EPS	1.08
Profit margin	21.242
Employees	268
EBITDA	14M 73M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+17.1% upside

Dividends
By Dow Jones
Next Earnings	24 lut 2026

Market Stats
By TradingEconomics
Market Cap	464M 2.2B
Previous open	38.67
Previous close	36.83

News Sentiment

By Acuity

38%

62%

106 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 sty 2026, 23:51 UTC

Earnings

Correction to Samsung Fourth-Quarter Net Profit Article

28 sty 2026, 23:49 UTC

Hot Stocks

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28 sty 2026, 23:19 UTC

Earnings

Samsung's Fourth-Quarter Net Profit Beats Consensus

28 sty 2026, 22:43 UTC

Earnings

Waste Management Logs Higher 4Q Profit as Revenue Rises

29 sty 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

29 sty 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

29 sty 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

29 sty 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

28 sty 2026, 23:49 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28 sty 2026, 23:30 UTC

Market Talk

Tesla to Use Car Factory for Robot Aims -- Market Talk

28 sty 2026, 23:28 UTC

Earnings

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28 sty 2026, 23:26 UTC

Earnings

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28 sty 2026, 23:21 UTC

Earnings

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 sty 2026, 23:18 UTC

Earnings

Acquisitions, Mergers, Takeovers

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 sty 2026, 22:58 UTC

Earnings

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 sty 2026, 22:48 UTC

Market Talk

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28 sty 2026, 22:45 UTC

Earnings

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28 sty 2026, 22:44 UTC

Earnings

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28 sty 2026, 22:43 UTC

Earnings

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28 sty 2026, 22:41 UTC

Earnings

Hot Stocks

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28 sty 2026, 22:41 UTC

Market Talk

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28 sty 2026, 22:41 UTC

Earnings

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28 sty 2026, 22:40 UTC

Earnings

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28 sty 2026, 22:39 UTC

Earnings

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28 sty 2026, 22:38 UTC

Earnings

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28 sty 2026, 22:37 UTC

Earnings

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28 sty 2026, 22:35 UTC

Earnings

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 sty 2026, 22:26 UTC

Market Talk

Earnings

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28 sty 2026, 22:20 UTC

Market Talk

Global Equities Roundup: Market Talk

28 sty 2026, 22:20 UTC

Market Talk

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

17.1% upside

12 Months Forecast

Average 43.75 USD 17.1%

High 55 USD

Low 32 USD

Based on 5 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

Buy

Hold

Sell

Based on 5 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

106 / 352 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.